JP Morgan Maintains Overweight on Sempra, Lowers Price Target to $99
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
JP Morgan analyst Aidan Kelly maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $102 to $99.
JP Morgan analyst Aidan Kelly maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $102 to $99.